Výsledky vyhledávání - "Dietmar Schnober"

Akademický článek

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

Autor: Jeanette A. Stewart, Lindsay A. Nelson, Michael S. Kristoffersen, Sonja Schölzel, Dietmar Schnober, Ulrich Thelen, William C. Stewart

Publikováno v: International Journal of Ophthalmology, Vol 6, Iss 2, Pp 155-159 (2013)

AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or pigmenta

Externí odkaz: https://doaj.org/article/2fef15dbd8154a32b251b777609f8526

Zobrazit plný text záznamu

Travoprost 0.004%/timolol 0.5% fixed combination in patients transitioning from fixed or unfixed bimatoprost 0.03%/timolol 0.5%

Autor: Maria-Luise Scherzer, Ivana Liehneova, Francisco J Muñoz Negrete, Dietmar Schnober

Publikováno v: Advances in Therapy. 28:661-670

Patients with glaucoma or ocular hypertension who do not achieve target intraocular pressure (IOP) using one hypotensive agent are often transitioned to combination therapy. Travoprost 0.004%/timolol 0.5% fixed combination (TTFC) has shown efficacy i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d9b7b5586acbcdb2c949243393abba
https://doi.org/10.1007/s12325-011-0043-z

Zobrazit plný text záznamu

Midterm response with latanoprost therapy in german ocular hypertension patients

Autor: Dietmar Schnober, Thomas Christ, Hans-Joachim Hofstetter, Ulrich Thelen, William C. Stewart

Publikováno v: Current eye research. 32(1)

The purpose of this prospective observational trial was to report the analysis of the midterm efficacy, safety, and discontinuation rates of a cohort of ocular hypertensive patients treated with latanoprost in Germany.A subanalysis of patients with o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33751d8a140c7469cdc35c39e65d0dc
https://pubmed.ncbi.nlm.nih.gov/17364735

Zobrazit plný text záznamu

Plný text ve formátu HTML

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

Autor: Douglas A Hubatsch, Dietmar Schnober, Maria-Luise Scherzer

Publikováno v: Clinical Ophthalmology (Auckland, N.Z.)

Dietmar Schnober,1 Douglas A Hubatsch,2 Maria-Luise Scherzer3 1Private Ophthalmology Practice, Werdohl, Germany; 2Alcon Laboratories, Inc., Fort Worth, TX, USA; 3Private Ophthalmology Practice, Regenstauf, Germany Purpose: To determine the efficacy a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53fade44b74b3b988617fc94d16d4e1
https://doi.org/10.2147/opth.s80880

Zobrazit plný text záznamu

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension

Autor: Stefan Pfennigsdorf, Hazel Cooper, Michael Froböse, Gerrit von Kistowski, Thomas Laube, Dietmar Schnober, Ulrich Thelen, Peter Eschstruth, Birgit Mäder, Christoph W Spraul, Osman Ramez

Publikováno v: Clinical Ophthalmology (Auckland, N.Z.)

Stefan Pfennigsdorf,1 Osman Ramez,2 Gerrit von Kistowski,3 Birgit Mäder,4 Peter Eschstruth,5 Michael Froböse,6 Ulrich Thelen,7 Christoph Spraul,8 Dietmar Schnober,9 Hazel Cooper,10 Thomas Laube111Polch Ophthalmology Practice, Polch, 2Buxtehude Opht

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4971d691a6f52f749bb5e4a8098439e6
https://doi.org/10.2147/opth.s31330

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání